Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy.

Jankauskas, Stanislovas S, Fahimeh Varzideh, Urna Kansakar, and Gaetano Santulli. “Targeting MiR-199a Reduces Fibrosis in Hypertrophic Cardiomyopathy.”. Journal of Molecular and Cellular Cardiology Plus 7 (2024): 100057.